- Home
- LXEO vs LANV Comparison
LXEO vs LANV Comparison
Compare LXEO & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- LANV
- Stock Information
- Founded
- LXEO 2017
- LANV 2015
- Country
- LXEO United States
- LANV China
- Employees
- LXEO N/A
- LANV N/A
- Industry
- LXEO
- LANV Blank Checks
- Sector
- LXEO
- LANV Finance
- Exchange
- LXEO Nasdaq
- LANV Nasdaq
- Market Cap
- LXEO 290.5M
- LANV 244.4M
- IPO Year
- LXEO 2023
- LANV N/A
- Fundamental
- Price
- LXEO $6.47
- LANV $2.14
- Analyst Decision
- LXEO Strong Buy
- LANV
- Analyst Count
- LXEO 7
- LANV 0
- Target Price
- LXEO $15.29
- LANV N/A
- AVG Volume (30 Days)
- LXEO 763.8K
- LANV 51.3K
- Earning Date
- LXEO 11-12-2025
- LANV 08-29-2025
- Dividend Yield
- LXEO N/A
- LANV N/A
- EPS Growth
- LXEO N/A
- LANV N/A
- EPS
- LXEO N/A
- LANV N/A
- Revenue
- LXEO N/A
- LANV $341,783,911.00
- Revenue This Year
- LXEO N/A
- LANV N/A
- Revenue Next Year
- LXEO N/A
- LANV $6.90
- P/E Ratio
- LXEO N/A
- LANV N/A
- Revenue Growth
- LXEO N/A
- LANV N/A
- 52 Week Low
- LXEO $1.45
- LANV $1.32
- 52 Week High
- LXEO $11.72
- LANV $2.69
- Technical
- Relative Strength Index (RSI)
- LXEO 67.21
- LANV 51.49
- Support Level
- LXEO $6.33
- LANV $2.02
- Resistance Level
- LXEO $6.90
- LANV $2.18
- Average True Range (ATR)
- LXEO 0.51
- LANV 0.13
- MACD
- LXEO 0.05
- LANV 0.01
- Stochastic Oscillator
- LXEO 62.04
- LANV 56.00
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.